Related Content
Search Google Scholar for:
|
|
Science 4 March 1994: Vol. 263. no. 5151, pp. 1284 - 1286 DOI: 10.1126/science.7510069
|
|
Articles
Science, Vol 263, Issue 5151, 1284-1286
Copyright © 1994 by American Association for the Advancement of Science
Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain
H Bodmer,
S Viville,
C Benoist,
and
D Mathis
Laboratoire de Genetique Moleculaire des Eucaryotes du CNRS, Strasbourg, France.
The invariant chain (Ii) binds nascent major histocompatibility complex (MHC) class II molecules, blocking peptide binding until the complex dissociates in the endosomes. This may serve to differentiate the MHC class I and II antigen presentation pathways and enable class II molecules to efficiently bind peptides in the endosomes. This hypothesis was addressed by probing spleen cells from a combination of knock-out and transgenic mice with a large panel of T cell hybridomas. The Ii molecule blocked the presentation of a range of endogenously synthesized epitopes, but some epitopes actually required Ii. Thus, the influence of Ii on presentation does not follow simple rules. In addition, mice expressing Ii were not tolerant to epitopes unmasked in its absence, a finding with possible implications for autoimmunity.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Loss of Invariant Chain Protects Nonobese Diabetic Mice against Type 1 Diabetes.
- R. J. Mellanby, C. H. Koonce, A. Monti, J. M. Phillips, A. Cooke, and E. K. Bikoff (2006)
J. Immunol.
177, 7588-7598
| Abstract »
| Full Text »
| PDF »
- Presence and regulation of messenger ribonucleic acids encoding components of the class II major histocompatibility complex-associated antigen processing pathway in the bovine corpus luteum..
- M. J Cannon, J. S Davis, and J. L Pate (2006)
Reproduction
131, 689-698
| Abstract »
| Full Text »
| PDF »
- Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
- B. E. Anderson, J. M. McNiff, D. Jain, B. R. Blazar, W. D. Shlomchik, and M. J. Shlomchik (2005)
Blood
105, 2227-2234
| Abstract »
| Full Text »
| PDF »
- Dissecting MHC Class II Export, B Cell Maturation, and DM Stability Defects in Invariant Chain Mutant Mice.
- C. H. Koonce and E. K. Bikoff (2004)
J. Immunol.
173, 3271-3280
| Abstract »
| Full Text »
| PDF »
- Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity.
- Y. Zhao, D. Boczkowski, S. K. Nair, and E. Gilboa (2003)
Blood
102, 4137-4142
| Abstract »
| Full Text »
| PDF »
- Effects of Prostaglandin F2{alpha} and Progesterone on the Ability of Bovine Luteal Cells to Stimulate T Lymphocyte Proliferation.
- M. J. Cannon, M. G. Petroff, and J. L. Pate (2003)
Biol Reprod
69, 695-700
| Abstract »
| Full Text »
| PDF »
- Second Class Minors: Molecular Identification of the Autosomal H46 Histocompatibility Locus as a Peptide Presented by Major Histocompatibility Complex Class II Molecules.
- H. Sahara and N. Shastri (2003)
J. Exp. Med.
197, 375-385
| Abstract »
| Full Text »
| PDF »
- Expression and Function of Transgenic HLA-DQ Molecules and Lymphocyte Development in Mice Lacking Invariant Chain.
- G. Rajagopalan, M. K. Smart, C. J. Krco, and C. S. David (2002)
J. Immunol.
169, 1774-1783
| Abstract »
| Full Text »
| PDF »
- Negligible Class II MHC Presentation of B Cell Receptor-Derived Peptides by High Density Resting B Cells.
- C. M. Snyder, X. Zhang, and L. J. Wysocki (2002)
J. Immunol.
168, 3865-3873
| Abstract »
| Full Text »
| PDF »
- De Novo Central Nervous System Processing of Myelin Antigen Is Required for the Initiation of Experimental Autoimmune Encephalomyelitis.
- S. M. Tompkins, J. Padilla, M. C. Dal Canto, J. P.-Y. Ting, L. Van Kaer, and S. D. Miller (2002)
J. Immunol.
168, 4173-4183
| Abstract »
| Full Text »
| PDF »
- {{alpha}}{{beta}}TCRs Differ in the Degree of Their Specificity for the Positively Selecting MHC/Peptide Ligand.
- P. Kraj, R. Pacholczyk, and L. Ignatowicz (2001)
J. Immunol.
166, 2251-2259
| Abstract »
| Full Text »
| PDF »
- A gene therapy approach for treating T-cell-mediated autoimmune diseases.
- C.-C. Chen, A. Rivera, N. Ron, J. P. Dougherty, and Y. Ron (2001)
Blood
97, 886-894
| Abstract »
| Full Text »
| PDF »
- Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells.
- S Sakamaki, N Takayanagi, N Yoshizaki, S Hayashi, T Takayama, J Kato, K Kogawa, N Yamauchi, N Takemoto, A Nobuoka, et al. (2000)
Gut
47, 236-241
| Abstract »
| Full Text »
| PDF »
- Interaction of Human Immunodeficiency Virus Type 2 Vpx and Invariant Chain.
- H. A. Pancio, N. Vander Heyden, K. Kosuri, P. Cresswell, and L. Ratner (2000)
J. Virol.
74, 6168-6172
| Abstract »
| Full Text »
| PDF »
- Subtle Effects on Myelin Basic Protein-Specific T Cell Responses Can Lead to a Major Reduction in Disease Susceptibility in Experimental Allergic Encephalomyelitis.
- C. Vowles, V. S. F. Chan, and H. C. Bodmer (2000)
J. Immunol.
165, 75-82
| Abstract »
| Full Text »
| PDF »
- Antigen Secreted from Noncytosolic Listeria monocytogenes Is Processed by the Classical MHC Class I Processing Pathway.
- H. L. Zwickey and T. A. Potter (1999)
J. Immunol.
162, 6341-6350
| Abstract »
| Full Text »
| PDF »
- Class II-Associated Invariant Chain Peptide-Independent Binding of Invariant Chain to Class II MHC molecules.
- W. P. Thayer, L. Ignatowicz, D. A. Weber, and P. E. Jensen (1999)
J. Immunol.
162, 1502-1509
| Abstract »
| Full Text »
| PDF »
- Exogenously Provided Peptides of a Self-antigen Can Be Processed into Forms that Are Recognized by Self-T Cells.
- A. K. Barlow, X. He, and C. Janeway Jr. (1998)
J. Exp. Med.
187, 1403-1415
| Abstract »
| Full Text »
| PDF »
- Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation.
- J. Deussing, W. Roth, P. Saftig, C. Peters, H. L. Ploegh, and J. A. Villadangos (1998)
PNAS
95, 4516-4521
| Abstract »
| Full Text »
| PDF »
- Invariant Chain-independent Function of H-2M in the Formation of Endogenous Peptide-Major Histocompatibility Complex Class II Complexes In Vivo.
- S. Kovats, C. E. Grubin, S. Eastman, P. deRoos, A. Dongre, L. V. Kaer, and A. Y. Rudensky (1998)
J. Exp. Med.
187, 245-251
| Abstract »
| Full Text »
| PDF »
- MHC Class II Expression in Double Mutant Mice Lacking Invariant Chain and DM Functions.
- G. Kenty, W. D. Martin, L. Van Kaer, and E. K. Bikoff (1998)
J. Immunol.
160, 606-614
| Abstract »
| Full Text »
| PDF »
- Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes.
- S. Tourne, T. Miyazaki, P. Wolf, H. Ploegh, C. Benoist, and D. Mathis (1997)
PNAS
94, 9255-9260
| Abstract »
| Full Text »
| PDF »
- In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM.
- L. Lightstone, R. Hargreaves, G. Bobek, M. Peterson, G. Aichinger, G. Lombardi, and R. Lechler (1997)
PNAS
94, 5772-5777
| Abstract »
| Full Text »
| PDF »
- Related Leucine-based Cytoplasmic Targeting Signals in Invariant Chain and Major Histocompatibility Complex Class II Molecules Control Endocytic Presentation of Distinct Determinants in a Single Protein.
- G. Zhong, P. Romagnoli, and R. N. Germain (1997)
J. Exp. Med.
185, 429-438
| Abstract »
| Full Text »
| PDF »
- T Helper Subset Differentiation in the Absence of Invariant Chain.
- D. R. Brown, K. Swier, N. H. Moskowitz, M. F. Naujokas, R. M. Locksley, and S. L. Reiner (1997)
J. Exp. Med.
185, 31-42
| Abstract »
| Full Text »
| PDF »
|
|